Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Long-COVID Syndrome | Research

Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan

Authors: Mary Rose Angeles, Sithara Wanni Arachchige Dona, Huong Dieu Nguyen, Long Khanh-Dao Le, Martin Hensher

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Concerns have grown that post-acute sequelae of COVID-19 may affect significant numbers of survivors. However, the analyses used to guide policy-making for Australia’s national and state re-opening plans have not incorporated non-acute illness in their modelling. We, therefore, develop a model by which to estimate the potential acute and post-acute COVID-19 burden using disability-adjusted life years (DALYs) associated with the re-opening of Australian borders and the easing of other public health measures, with particular attention to longer-term, post-acute consequences and the potential impact of permanent functional impairment following COVID-19.

Methods

A model was developed based on the European Burden of Disease Network protocol guideline and consensus model to estimate the burden of COVID-19 using DALYs. Data inputs were based on publicly available sources. COVID-19 infection and different scenarios were drawn from the Doherty Institute’s modelling report to estimate the likely DALY losses under the Australian national re-opening plan. Long COVID prevalence, post-intensive care syndrome (PICS) and potential permanent functional impairment incidences were drawn from the literature. DALYs were calculated for the following health states: the symptomatic phase, Long COVID, PICS and potential permanent functional impairment (e.g., diabetes, Parkinson’s disease, dementia, anxiety disorders, ischemic stroke). Uncertainty and sensitivity analysis were performed to examine the robustness of the results.

Results

Mortality was responsible for 72-74% of the total base case COVID-19 burden. Long COVID and post-intensive care syndrome accounted for at least 19 and 3% of the total base case DALYs respectively. When included in the analysis, potential permanent impairment could contribute to 51-55% of total DALYs lost.

Conclusions

The impact of Long COVID and potential long-term post-COVID disabilities could contribute substantially to the COVID-19 burden in Australia’s post-vaccination setting. As vaccination coverage increases, the share of COVID-19 burden driven by longer-term morbidity rises relative to mortality. As Australia re-opens, better estimates of the COVID-19 burden can assist with decision-making on pandemic control measures and planning for the healthcare needs of COVID-19 survivors. Our estimates highlight the importance of valuing the morbidity of post-COVID-19 sequelae, above and beyond simple mortality and case statistics.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kompas T, Grafton RQ, Che TN, Chu L, Camac J. Health and economic costs of early and delayed suppression and the unmitigated spread of COVID-19: the case of Australia. PLoS One. 2021;16(6):e0252400.CrossRefPubMedPubMedCentral Kompas T, Grafton RQ, Che TN, Chu L, Camac J. Health and economic costs of early and delayed suppression and the unmitigated spread of COVID-19: the case of Australia. PLoS One. 2021;16(6):e0252400.CrossRefPubMedPubMedCentral
8.
go back to reference Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.CrossRefPubMed Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.CrossRefPubMed
9.
go back to reference Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27.CrossRefPubMedPubMedCentral Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27.CrossRefPubMedPubMedCentral
10.
go back to reference Wyper G, Assunção R, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Public Health. 2021;66:4.CrossRef Wyper G, Assunção R, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Public Health. 2021;66:4.CrossRef
12.
go back to reference Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502–9.CrossRefPubMed Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502–9.CrossRefPubMed
17.
go back to reference Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827.CrossRefPubMedPubMedCentral Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827.CrossRefPubMedPubMedCentral
19.
go back to reference Liu B, Jayasundara D, Pye V, Dobbins T, Dore GJ, Matthews G, et al. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Region Health-Western Pacific. 2021;12:100193.CrossRef Liu B, Jayasundara D, Pye V, Dobbins T, Dore GJ, Matthews G, et al. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Region Health-Western Pacific. 2021;12:100193.CrossRef
20.
go back to reference Rousseau A-F, Minguet P, Colson C, Kellens I, Chaabane S, Delanaye P, et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care. 2021;11(1):1–9.CrossRef Rousseau A-F, Minguet P, Colson C, Kellens I, Chaabane S, Delanaye P, et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care. 2021;11(1):1–9.CrossRef
21.
go back to reference Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14(1):R6–R.CrossRefPubMedPubMedCentral Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14(1):R6–R.CrossRefPubMedPubMedCentral
22.
go back to reference Hofhuis JG, Schrijvers AJ, Schermer T, Spronk PE. Health-related quality of life in ICU survivors—10 years later. Sci Rep. 2021;11(1):1–10.CrossRef Hofhuis JG, Schrijvers AJ, Schermer T, Spronk PE. Health-related quality of life in ICU survivors—10 years later. Sci Rep. 2021;11(1):1–10.CrossRef
23.
go back to reference Byrnes J, Ball J, Gao L, Kai Chan Y, Kularatna S, Stewart S, et al. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial. J Med Econ. 2019;22(9):945–52.CrossRefPubMed Byrnes J, Ball J, Gao L, Kai Chan Y, Kularatna S, Stewart S, et al. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial. J Med Econ. 2019;22(9):945–52.CrossRefPubMed
26.
go back to reference Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official J Assoc Med Microbiol Infect Dis Canada. 2020;5(4):223–34. Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official J Assoc Med Microbiol Infect Dis Canada. 2020;5(4):223–34.
27.
go back to reference Martin C, Luteijn M, Letton W, Robertson J, McDonald S. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One. 2021;16(12):e0260843.CrossRefPubMedPubMedCentral Martin C, Luteijn M, Letton W, Robertson J, McDonald S. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One. 2021;16(12):e0260843.CrossRefPubMedPubMedCentral
28.
go back to reference Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55. Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55.
29.
go back to reference Zhang J, Yu KF. What’s the relative risk?A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.CrossRefPubMed Zhang J, Yu KF. What’s the relative risk?A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.CrossRefPubMed
30.
go back to reference Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078–87.CrossRefPubMedPubMedCentral Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078–87.CrossRefPubMedPubMedCentral
31.
go back to reference Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.PubMedCrossRef Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.PubMedCrossRef
32.
go back to reference Fortini A, Torrigiani A, Sbaragli S, Lo Forte A, Crociani A, Cecchini P, et al. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge. Infection. 2021;49(5):1007–15.CrossRefPubMedPubMedCentral Fortini A, Torrigiani A, Sbaragli S, Lo Forte A, Crociani A, Cecchini P, et al. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge. Infection. 2021;49(5):1007–15.CrossRefPubMedPubMedCentral
33.
go back to reference Health F. A detailed study of patients with long-haul COVID; 2021. Health F. A detailed study of patients with long-haul COVID; 2021.
34.
go back to reference Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.CrossRefPubMedPubMedCentral Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.CrossRefPubMedPubMedCentral
35.
go back to reference Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, Martín-Toledano M, López-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945.CrossRefPubMedPubMedCentral Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, Martín-Toledano M, López-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945.CrossRefPubMedPubMedCentral
36.
go back to reference Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients? Diabetes Metab Syndr. 2021;15(1):147–8.CrossRefPubMed Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients? Diabetes Metab Syndr. 2021;15(1):147–8.CrossRefPubMed
38.
go back to reference Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11–30.CrossRefPubMed Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11–30.CrossRefPubMed
39.
go back to reference McCue C, Cowan R, Quasim T, Puxty K, McPeake J. Long term outcomes of critically ill COVID-19 pneumonia patients: early learning. Intensive Care Med. 2021;47(2):240–1.CrossRefPubMed McCue C, Cowan R, Quasim T, Puxty K, McPeake J. Long term outcomes of critically ill COVID-19 pneumonia patients: early learning. Intensive Care Med. 2021;47(2):240–1.CrossRefPubMed
42.
go back to reference John D, Narassima MS, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619.CrossRefPubMed John D, Narassima MS, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619.CrossRefPubMed
43.
go back to reference Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, et al. The burden of disease due to COVID-19 in Korea using disability-adjusted life years. J Korean Med Sci. 2020;35(21):e199-e.CrossRef Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, et al. The burden of disease due to COVID-19 in Korea using disability-adjusted life years. J Korean Med Sci. 2020;35(21):e199-e.CrossRef
44.
go back to reference Nurchis MC, Pascucci D, Sapienza M, Villani L, D'Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233.CrossRefPubMedCentral Nurchis MC, Pascucci D, Sapienza M, Villani L, D'Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233.CrossRefPubMedCentral
45.
go back to reference Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, et al. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. Int J Equity Health. 2021;20(1):214.CrossRefPubMedPubMedCentral Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, et al. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. Int J Equity Health. 2021;20(1):214.CrossRefPubMedPubMedCentral
46.
go back to reference Salinas-Escudero G, Toledano-Toledano F, García-Peña C, Parra-Rodríguez L, Granados-García V, Carrillo-Vega MF. Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Front Public Health. 2021;9:686700.CrossRefPubMedPubMedCentral Salinas-Escudero G, Toledano-Toledano F, García-Peña C, Parra-Rodríguez L, Granados-García V, Carrillo-Vega MF. Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Front Public Health. 2021;9:686700.CrossRefPubMedPubMedCentral
Metadata
Title
Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan
Authors
Mary Rose Angeles
Sithara Wanni Arachchige Dona
Huong Dieu Nguyen
Long Khanh-Dao Le
Martin Hensher
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-13169-x

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue